Trinity Biotech (TRIB) Return on Assets (2009 - 2025)

Trinity Biotech (TRIB) has reported Return on Assets for 17 consecutive years, with 0.0% the latest figure, recorded in Q4 2025.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Assets advanced to 0.0% in Q4 2025 per TRIB's latest filing, from 0.0% in the prior quarter.
• Over the last five years, Return on Assets for TRIB reached as high as 0.0% in Q4 2023 and fell as low as 0.0% in Q3 2024.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
• The largest YoY upside for Return on Assets was 0 bps in 2021 against a maximum downside of 0 bps in 2021.
• Year by year, Return on Assets stood at 0.0% in 2021, then plunged by 33 bps to 0.0% in 2022, then soared by 669 bps to 0.0% in 2023, then plunged by 174 bps to 0.0% in 2024, then soared by 66 bps to 0.0% in 2025.
• According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2025, Q2 2025, and Q4 2024 respectively.